Active Not RecruitingNCT05387837
Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME
PHASE2 · 50 planned enrolment
- Countries listed
- 1
- Registry update
- May 4, 2025
immortal.lifeTrial registrations containing the exact intervention label D-4517.2.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 50 planned enrolment
PHASE1 · 16 planned enrolment